Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders

Gastroenterology. 2007 Jun;132(7):2287-90. doi: 10.1053/j.gastro.2007.04.057.
No abstract available

MeSH terms

  • Drug Approval
  • Gastrointestinal Agents / adverse effects*
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Diseases / drug therapy*
  • Gastrointestinal Motility / drug effects
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Irritable Bowel Syndrome / drug therapy
  • Ischemia / chemically induced
  • Marketing of Health Services*
  • Serotonin Receptor Agonists / adverse effects*
  • Serotonin Receptor Agonists / therapeutic use
  • Technology, Pharmaceutical / trends*
  • United States

Substances

  • Gastrointestinal Agents
  • Indoles
  • Serotonin Receptor Agonists
  • tegaserod